ωV-3 fatty acid supplementation does not affect autism spectrum disorder in children: A systematic review and meta-analysis1-3

Journal of Nutrition

Volumn 147, Issue 3, 2017, Pages 367-376

  Horvath, Andrea ^a   Łukasik, Jan ^a   Szajewska, Hania ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Autism; Children; DHA; EPA; Randomized controlled trial; V 3 fatty acids

Indexed keywords

CYTOKINE; OMEGA 3 FATTY ACID; PLACEBO;

ABERRANT BEHAVIOR CHECKLIST; ADAPTIVE BEHAVIOR; ADAPTIVE BEHAVIOR SCALE; ADVERSE EVENT; ARTICLE; AUTISM; BEHAVIOR ASSESSMENT; BEHAVIOR CHANGE; BEHAVIORAL ASSESSMENT SYSTEM FOR CHILDREN; CHECKLIST; CHILD; CLINICAL EFFECTIVENESS; CLINICAL EVALUATION; CLINICAL GLOBAL IMPRESSION SCALE; COCHRANE LIBRARY; COMPARATIVE STUDY; DAILY LIFE ACTIVITY; DIET SUPPLEMENTATION; EMBASE; EVIDENCE BASED PRACTICE; FUNCTIONAL STATUS; HUMAN; LETHARGY; MEDICATION COMPLIANCE; MEDLINE; META ANALYSIS; OUTCOME ASSESSMENT; RANDOMIZED CONTROLLED TRIAL (TOPIC); SOCIAL ADAPTATION; SOCIAL COMPETENCE; SYMPTOM; SYSTEMATIC REVIEW; AUTISM SPECTRUM DISORDER; DIETARY SUPPLEMENT;

AUTISM SPECTRUM DISORDER; CHILD; DIETARY SUPPLEMENTS; FATTY ACIDS, OMEGA-3; HUMANS;

EID: 85021855052     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: 10.3945/jn.116.242354     Document Type: Article

References (20)

1. American Psychiatric Association. Autism spectrum disorder. In: Diagnostic and statistical manual of mental disorders. 5th ed. Arlington (VA): American Psychiatric Association; 2013. p. 50.
2. WHO. Autism spectrum disorders [Internet]. [cited 2016 Nov 6]. Available from: http://www.who.int/mediacentre/factsheets/autismspectrum-disorders/en.
3. Lai MC, Lombardo MV, Baron-Cohen S. Autism. Lancet 2014;383: 896-910.
4. Anagnostou E, Hansen R. Medical treatment overview: traditional and novel psycho-pharmacological and complementary and alternative medications. Curr Opin Pediatr 2011;23:621-7.
5. Zeman M, Jirak R, Vecka M, Raboch J, Zak A. N-3 polyunsaturated fatty acids in psychiatric diseases: mechanisms and clinical data. Neuroendocrinol Lett 2012;33:736-48.
6. Sliwinski S, Croonenberghs J, Christophe A, Deboutte D, Maes M. Polyunsaturated fatty acids: do they have a role in the pathophysiology of autism? Neuroendocrinol Lett 2006;27:465-71.
7. Vancassel S, Durand G, Barthélémy C, Lejeune B, Martineau J, Guilloteau D, Andrès C, Chalon S. Plasma fatty acid levels in autistic children. Prostaglandins Leukot Essent Fatty Acids 2001;65:1-7.
8. James S, Montgomery P, Williams K. Omega-3 fatty acids supplementation for autism spectrum disorders (ASD). Cochrane Database Syst Rev 2011;11:CD007992.
9. Higgins JPT, Green S, editors. Cochrane handbook for systematic reviews of interventions: version 5.1.0 [Internet]. [cited 2016 Nov 6]. Available from: http://www.handbook.cochrane.org.
10. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009;6:e1000097.
11. Schünemann H, Brozek J, Guyatt G, Oxman A, editors. GRADE handbook for grading quality of evidence and strength of recommendations [Internet]. [cited 2016 Nov 6]. Available from: gdt.guidelinedevelopment. org/app/handbook/handbook.html.
12. Amminger GP, Berger GE, Schäfer MR, Klier C, Friedrich MH, Feucht M. Omega-3 fatty acids supplementation in children with autism: a double-blind randomized, placebo-controlled pilot study. Biol Psychiatry 2007;61:551-3.
13. Higgins JPT, Deeks JJ. Selecting studies and collecting data. In: Higgins JPT, Green S, editors. Cochrane handbook for systematic reviews of interventions: version 5.1.0 [Internet]. [cited 2016 Nov 6]. Available from: http://www.handbook.cochrane.org.
14. Mankad D, Dupuis A, Smile S, Roberts W, Brian J, Lui T, Genore L, Zaghloul D, Iaboni A, Marcon PM, et al. A randomized, placebo controlled trial of omega-3 fatty acids in the treatment of young children with autism. Mol Autism 2015;6:18.
15. Bent S, Bertoglio K, Ashwood P, Bostrom A, Hendren RL. A pilot randomized controlled trial of omega-3 fatty acids for autism spectrum disorder. J Autism Dev Disord 2011;41:545-54.
16. Bent S, Hendren RL, Zandi T, Law K, Choi JE, Widjaja F, Kalb L, Nestle J, Law P. Internet-based, randomized, controlled trial of omega-3 fatty acids for hyperactivity in autism. J Am Acad Child Adolesc Psychiatry 2014;53:658-66.
17. Higgins JPT, Deeks JJ. Special topics in statistics. In: Higgins JPT, Green S, editors. Cochrane handbook for systematic reviews of interventions: version 5.1.0 [Internet]. 2008 [cited 2016 Nov 6]. Available from: http://www.handbook.cochrane.org.
18. Egger M, Smith GD, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315:629-34.
19. Voigt RG, Mellon MW, Katusic SK, Weaver AL, Matern D, Mellon B, Jensen CL, Barbaresi WJ. Dietary docosahexaenoic acid supplementation in children with autism. J Pediatr Gastroenterol Nutr 2014;58:715-22.
20. EFSA Scientific Committee. Statement on the benefits of fish/seafood consumption compared to the risks of methylmercury in fish/seafood. EFSA J 2015;13:1-36.